UiPath (NYSE:PATH – Free Report) had its price objective cut by Scotiabank from $15.00 to $12.00 in a research report report ...

UiPath (NYSE:PATH – Free Report) had its price target decreased by Morgan Stanley from $16.00 to $12.00 in a report published ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

ARK also bought 79,201 shares of IBOTTA INC (NASDAQ:IBTA) across its ARKW and ARKF ETFs, with a total value of approximately $3.17 million. Notably, this purchase adds to ARK’s ongoing accumulation of ...

BMO Capital analyst Keith Bachman lowered the firm’s price target on UiPath (PATH) to $11.50 from $16 and keeps a Market Perform rating on the ...

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...

The semiconductor company named Lip-Bu Tan, a former board m ...

Learn more about whether Open Text Corporation or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Manhattan Associates, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

UiPath's growth slows to a crawl as it chases agentic AI dream with Peak acquisition, and its stock falls sharply - SiliconANGLE ...

UiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and ...